FGL1 and diabetes mellitus: Elevated circulating HFREP1 concentrations have been reported in individuals with impaired glucose tolerance and newly diagnosed diabetes, with positive associations with indices of insulin resistance, suggesting potential utility as a biomarker for glucose intolerance [45,46,47].